维普中文期刊产品整合服务
49篇 您的检索式:作者名="HAVERKAMP W"
    题名 作者 年代 出处 被引量
1Efficacy and safety of d, 1-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest显示文摘Haverkamp W Martines RA Hief C et ai 1997J Am Coll Cardiol1997,30,:1
2Coagulation of ventricular myocardium using radiofrequency alternating current: bio-physical aspects and experimental findings显示文摘Haverkamp W Hindricks G Gulker H 1998Pacing Clin Electrophysiol1998,12,12:1
3Update on the cardiac safety of moxifloxacin显示文摘Haverkamp W Kruesmann F Fritsch A 2012Curr Drug Saf2012,7,2:1
4Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation 显示文摘Eckardt L Breithardt G Haverkamp W 2002J Pharmacol Exp Ther2002,300,1:1
5Autosomal recessivelong-QT syndrome (Jervell Lange-Nielsen syndrome) is genetically heteroge-neous显示文摘Schulze-Bahr E Haverkamp W Wedekind H 1997Hum Genet1997,100,56:1
6Revision rate after short-stem total hip arthroplasty显示文摘Jakob van Oldenrijk Jeroen Molleman Michel Klaver Rudolf W Poolman Daniel Haverkamp 2014Acta Orthopaedica2014,,3:1
7Clofilium in the isolated perfused rabbit heart: a new model to study proarrhythmia induced by class III antiarrhythmic drugs显示文摘JOHNA R MERTENS H HAVERKAMP W 1998Basic Res Cardiol1998,93,2:1
8显示文摘Djonlagic H Haverkamp W Breithardt G 2002Circulation2002,106,:1
9Antiarrhythmic therapy in heart failure显示文摘Eckardt L Haverkamp W Breithardt G 2002Heart Fail Monit2002,2,4:1
10Update on the cardiac safety of moxifloxacin显示文摘HAVERKAMP W KRUESMANN F FRITSCH A 2012Current Drug Safety2012,7,2:1
11Report on a policy conference of the European Society of Cardiology显示文摘HAVERKAMP W BREITHARDT G CAMM A J et aL The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications 2000Eur Heart J2000,21,15:1
12Congenital long QT syndrome显示文摘Haverkamp W 2007Herz2007,32,3:1
13Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes 显示文摘Rolf S Haverkamp W Borggrefe M 2000Naunyn Schmiedebergs Arch Pharmacol2000,362,1:1
14Heart rate as a target for the prevention of sudden death 显示文摘Haverkamp W Breithardt G 1999Eur Heart J1999,20,1:1
15Incidence, preva-lence, and antithrombotic management of atrial fibrillation in elderlyGermans显示文摘Ohlijieier C Mikolajczyk R Haverkamp W 2013Europace2013,15,10:1
16Comparison of d,1-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coroary artery disease显示文摘Bocker D Haverkamp W Block M 1996Circulation1996,94,:1
17Arrhythmogenic right ventricular cardiomyopathy:diagnosis and risk stratification显示文摘Boldt LH Haverkamp W 2009Herz2009,34,4:1
18Physician-induced Torsade de Pointes:Therapeutic implications显示文摘Haverkamp W Moennig G Schulze-Bahr E 2002Cardiov Ther2002,16,2:1
19Congenital long QT syndrome 显示文摘Haverkamp W 2007Herz2007,32,3:1
20QT-Syndrome显示文摘Haverkamp W M nning G Schulze-Bahr H 2001J Kardiologie2001,8,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费